{"filing":{"accession_number":"0001493152-26-032777","cik":"0001904286","ticker":"MIRA","company_name":"MIRA PHARMACEUTICALS, INC.","form":"8-K","filing_date":"2026-07-10","report_date":null,"primary_document":"form8-k.htm","primary_document_url":"https://www.sec.gov/Archives/edgar/data/1904286/000149315226032777/form8-k.htm"},"events":[{"id":16965,"run_id":15190,"accession_number":"0001493152-26-032777","anchor_item_number":null,"event_type":"operational_other","event_domain":"operational","is_material":true,"confidence":0.75,"summary":"The filing discloses positive preclinical study results for MIRA-55, a lead drug candidate, demonstrating favorable oral bioavailability and tissue distribution. This is a material operational/development milestone for a clinical-stage pharmaceutical company, as it advances a key pipeline asset and supports continued development strategy. The event does not fit earnings_release (no financial results), but represents a significant product development achievement material to investors assessing the company's pipeline progress.","company_name":"MIRA PHARMACEUTICALS, INC.","ticker":"MIRA","filing_date":"2026-07-10","form":"8-K","submitted_at":null,"items":null}],"classifications":[{"id":15233,"accession_number":"0001493152-26-032777","item_number":null,"item_title":null,"event_type":"operational_other","event_domain":"operational","is_material":true,"confidence":0.75,"reasoning":"The filing discloses positive preclinical study results for MIRA-55, a lead drug candidate, demonstrating favorable oral bioavailability and tissue distribution. This is a material operational/development milestone for a clinical-stage pharmaceutical company, as it advances a key pipeline asset and supports continued development strategy. The event does not fit earnings_release (no financial results), but represents a significant product development achievement material to investors assessing the company's pipeline progress.","classifier_version":"claude-haiku-4-5-20251001+prompt-a85dd512","taxonomy_version":"v1.3","classified_at":"2026-07-10T12:01:40.654794+00:00","company_name":"MIRA PHARMACEUTICALS, INC.","ticker":"MIRA","filing_date":"2026-07-10"}]}